Related Experiment Videos

Sequence variability of the meningococcal lactoferrin-binding protein LbpB

A Pettersson1, J van der Biezen, V Joosten

  • 1Department of Molecular Cell Biology and Institute of Biomembranes, Utrecht University, 3584 CH, Utrecht, The Netherlands.

Gene
|May 8, 1999
PubMed

Insights

Sequence variability in Neisseria meningitidis LbpB, a vaccine candidate, was analyzed. High variability in key regions presents challenges for vaccine development but offers potential for epidemiological tracking.

Area of Science:

  • Microbiology
  • Immunology
  • Vaccine Development

Background:

  • Neisseria meningitidis is a significant human pathogen.
  • The lactoferrin receptor (Lbp) facilitates N. meningitidis iron acquisition.
  • LbpB is a key component of the lactoferrin receptor and a potential vaccine target.

Purpose of the Study:

  • To investigate the sequence variability of the LbpB protein from Neisseria meningitidis.
  • To assess the implications of LbpB sequence diversity for vaccine development and epidemiological studies.

Main Methods:

  • Amino acid sequencing of the LbpB protein from multiple N. meningitidis strains.
  • Comparative analysis of LbpB sequences to identify regions of variability.

Main Results:

  • LbpB sequences from five strains showed 70-80% amino acid identity.
  • Two distinct regions with high variability and negative charge content were identified.
  • One variable region exhibited length polymorphism, being absent in some strains.
  • The second variable region, present in all strains, showed significant sequence divergence.

Conclusions:

  • High sequence variability in LbpB poses challenges for developing a broadly protective meningococcal vaccine.
  • The identified variable regions in LbpB may serve as valuable markers for epidemiological surveillance and strain typing.

Related Concept Videos